Thursday, October 19, 2017 12:22:07 AM
Not only did Dr. Norchi accept my invite but he actually took the time to reply back. Basically he assured me that he and the team are more focused on executing operational and R&D plans- which was very reassuring to hear.
In my reply back that I just sent, I actually said that it seems like that cat has been let of the bag, so to speak, and I provided him with the url to that FDA page. It's a bit of a risk on my part (I don't want to tick him off), but I thought he'd genuinely like to know.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM